Departamento de Medicina Interna, Area de Medicina Vascular-Madrid, Clinica Universidad de Navarra, Madrid, Spain.
Department of Medical Sciences, University of Turin, Turin, Italy.
Curr Obes Rep. 2024 Sep;13(3):461-474. doi: 10.1007/s13679-024-00560-5. Epub 2024 Mar 23.
This integrative search aimed to provide a scoping overview of the relationships between the benefits and harms of alcohol drinking with cardiovascular events as associated to body fat mass and fatty liver diseases, as well as offering critical insights for precision nutrition research and personalized medicine implementation concerning cardiovascular risk management associated to ethanol consumption.
Frequent alcohol intake could contribute to a sustained rise in adiposity over time. Body fat distribution patterns (abdominal/gluteus-femoral) and intrahepatic accumulation of lipids have been linked to adverse cardiovascular clinical outcomes depending on ethanol intake. Therefore, there is a need to understand the complex interplay between alcohol consumption, adipose store distribution, metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular events in adult individuals. The current narrative review deals with underconsidered and apparently conflicting benefits concerning the amount of alcohol intake, ranging from abstention to moderation, and highlights the requirements for additional robust methodological studies and trials to interpret undertrained and existing controversies. The conclusion of this review emphasizes the need of newer multifaceted clinical approaches for precision medicine implementation, considering epidemiological strategies and pathophysiological mechanistic. Newer investigations and trials should be derived and performed particularly focusing both on alcohol's objective consequences as putatively mediated by fat deposition, including associated roles in fatty liver disease as well as to differentiate the impact of different levels of alcohol consumption (absence or moderation) concerning cardiovascular risks and accompanying clinical manifestations. Indeed, the threshold for the safe consumption of alcoholic drinks remains to be fully elucidated.
本综述旨在全面概述饮酒的益处和危害与心血管事件之间的关系,这些关系与体脂质量和脂肪肝疾病有关,并为精准营养研究和个性化医学实施提供关键见解,以管理与乙醇摄入相关的心血管风险。
频繁饮酒可能会导致脂肪持续增加。脂肪分布模式(腹部/臀部-股部)和肝脏内脂质蓄积与心血管不良临床结局有关,具体取决于乙醇的摄入量。因此,需要了解酒精摄入、脂肪储存分布、代谢功能障碍相关脂肪性肝病(MASLD)和成年人心血管事件之间的复杂相互作用。目前的叙述性综述涉及到对饮酒量(从戒酒到适度饮酒)的潜在益处和明显的益处进行讨论,强调需要进行更多的稳健方法学研究和试验,以解释尚未得到充分研究和存在争议的问题。本综述的结论强调需要采用新的多方面临床方法来实施精准医学,同时考虑到流行病学策略和病理生理机制。应开展和进行新的研究和试验,特别关注脂肪沉积介导的酒精的客观后果,包括其在脂肪肝疾病中的相关作用,以及区分不同水平的酒精摄入(戒酒或适度饮酒)对心血管风险和伴随的临床症状的影响。事实上,安全饮酒的阈值仍有待充分阐明。